Letrozole in Breast Cancer [1] (multiple letters)

New England Journal of Medicine

Volumn 350, Issue 7, 2004, Pages 727-730

  Buzdar, Aman U ^a   Hietanen, Päivi ^b   Mäkelä, Marjukka ^c   Shahab, Nasir ^d   Harris, Susan R ^e   Hellman, Samuel ^f   Hellman, Deborah ^g   Goss, Paul E ^h   Ingle, James N ⁱ   Pater, Joseph L ^j   Bryant, John ^k   Wolmark, Norman ^l   Burstein, Harold J ^m  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Finnish Office for Health Technology ^*

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF MISSOURI   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF CHICAGO   (United States)

^g UNIVERSITY OF MARYLAND   (United States)

^h PRINCESS MARGARET HOSPITAL   (Canada)

ⁱ MAYO CLINIC   (United States)

^j QUEEN S UNIVERSITY   (Canada)

^k UNIVERSITY OF PITTSBURGH   (United States)

^l ALLEGHENY GENERAL HOSPITAL   (United States)

^m DANA FARBER CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LETROZOLE; TAMOXIFEN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AROMATASE INHIBITOR; ENZYME INHIBITOR; NITRILE; TRIAZOLE DERIVATIVE;

ARTHRITIS; BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; FOLLOW UP; FRACTURE; HUMAN; LETTER; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; TREATMENT PLANNING; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; FEMALE; METHODOLOGY; NEOPLASM; NOTE; TIME; MORTALITY; TUMOR RECURRENCE; DISEASE FREE SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ETHICS; RANDOMIZED CONTROLLED TRIAL; STANDARD;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; ENZYME INHIBITORS; FEMALE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; NITRILES; POSTMENOPAUSE; RESEARCH DESIGN; TAMOXIFEN; TIME FACTORS; TRIAZOLES; NEOPLASM RECURRENCE, LOCAL; DISEASE-FREE SURVIVAL; RANDOMIZED CONTROLLED TRIALS;

EID: 12144290395     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200402123500718     Document Type: Letter

References (0)